Transdermal Delivery of Mitochondrial-Targeted Hydrogen Sulphide Donor, AP39 Protects Against 6-Hydroxydopamine-induced Mitochondrial Dysfunction.

Mandeep Kaur Marwah,Bahareh Manhoosh,Hala Shokr, Mohamad Anas Al Tahan, Roderick Stewart,Mohammed Iqbal,Lorena Diaz Sanchez, Sewa Abdullah,Shakil Ahmad,Keqing Wang,Karan Singh Rana,Lissette Sanchez-Aranguren

European journal of pharmaceutics and biopharmaceutics（2023）

引用 0|浏览22

暂无评分

关键词

Transdermal drug delivery,Sustained release,Mitochondrial bioenergetics,Neurodegenerative conditions,Hydrogen sulphide donors,Transdermal drug delivery,Sustained release,Mitochondrial bioenergetics,Neurodegenerative conditions,Transdermal drug delivery,Hydrogen sulphide donors,Sustained release,Mitochondrial bioenergetics,Neurodegenerative conditions,Hydrogen sulphide donors

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要